INY-03-041 trihydrochloride
|
I659395-5mg
|
≥99% |
N/A |
5mg
|
¥ 17500.9
|
期货,请咨询 |
阿拉丁 |
INY-03-041 trihydrochloride
|
I659395-1mg
|
≥99% |
N/A |
1mg
|
¥ 7900.9
|
期货,请咨询 |
阿拉丁 |
iMDK quarterhydrate
|
I659360-5mg
|
≥99% |
N/A |
5mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Ipratropium-d3bromide
|
I659274-5mg
|
≥98% |
N/A |
5mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
Ipratropium-d3bromide
|
I659274-1mg
|
≥98% |
N/A |
1mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
Inosine-13C5
|
I659230-5mg
|
≥99% |
N/A |
5mg
|
¥ 6000.9
|
期货,请咨询 |
阿拉丁 |
Inosine-13C5
|
I659230-1mg
|
≥99% |
N/A |
1mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Inosine-13C5
|
I659230-10mg
|
≥99% |
N/A |
10mg
|
¥ 10200.9
|
期货,请咨询 |
阿拉丁 |
INCB059872 dihydrochloride
|
I659229-5mg
|
≥98% |
N/A |
5mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
INCB059872 dihydrochloride
|
I659229-1mg
|
≥98% |
N/A |
1mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
INCB059872 dihydrochloride
|
I659229-10mg
|
≥98% |
N/A |
10mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
IFN-γ Antagonist 1 acetate
|
I659161-5mg
|
≥99% |
N/A |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
IFN-γ Antagonist 1 acetate
|
I659161-1mg
|
≥99% |
N/A |
1mg
|
¥ 500.9
|
期货,请咨询 |
阿拉丁 |
IFN-γ Antagonist 1 acetate
|
I659161-10mg
|
≥99% |
N/A |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
ICA-105665
|
I659128-5mg
|
≥99% |
N/A |
5mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
ICA-105665
|
I659128-50mg
|
≥99% |
N/A |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
ICA-105665
|
I659128-25mg
|
≥99% |
N/A |
25mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
ICA-105665
|
I659128-10mg
|
≥99% |
N/A |
10mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
IRAK inhibitor 4 trans
|
I659117-5mg
|
≥99% |
N/A |
5mg
|
¥ 6700.9
|
期货,请咨询 |
阿拉丁 |
IRAK inhibitor 4 trans
|
I659117-2mg
|
≥99% |
N/A |
2mg
|
¥ 4466.9
|
期货,请咨询 |
阿拉丁 |
INCB3344 R-isomer
|
I659067-5mg
|
≥97% |
N/A |
5mg
|
¥ 3900.9
|
期货,请咨询 |
阿拉丁 |
INCB3344 R-isomer
|
I659067-50mg
|
≥97% |
N/A |
50mg
|
¥ 19000.9
|
期货,请咨询 |
阿拉丁 |
INCB3344 R-isomer
|
I659067-10mg
|
≥97% |
N/A |
10mg
|
¥ 5900.9
|
期货,请咨询 |
阿拉丁 |
IKKγ NBD Inhibitory Peptide TFA
|
I659065-50mg
|
≥99% |
N/A |
50mg
|
¥ 14000.9
|
期货,请咨询 |
阿拉丁 |